This webinar will explore the benefits of strategic, deliberate partnerships in order to improve access to quality diagnostic laboratory services, support more timely answers to advance patient care, and serve as a defense mechanism against acquisition
Partnership between Mindera and PBM aims to optimize treatment matches for the disorder, as some drugs cost nearly six figures annually
More aggressive use of artificial intelligence may mitigate issues that lead to the uneven impact of the disease on this group.
An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.
Robin Divine, MBA, president and CEO of TriCore Reference Laboratories, discusses key recent developments in the lab industry and predictions for 2024.